基于肺动脉CT血管成像的自动三维容积测量联合超声心动图检测肺动脉高压
这项回顾性诊断准确性研究纳入70例疑似肺动脉高压患者,评估CTPA自动三维容积测量中央肺动脉单独及联合超声心动图估测肺动脉收缩压的诊断准确性,以右心导管测量的有创平均肺动脉压为金标准。结果显示,主肺动脉容积与有创平均肺动脉压相关性最强(r=0.76,p<0.001);联合超声心动图肺动脉收缩压构建的预测模型与有创平均肺动脉压相关性达r=0.89(p<0.001),预测肺动脉高压的AUC为0.94,高于单独主肺动脉容积(0.90)或单独超声心动图肺动脉收缩压(0.92)。预测平均肺动脉压>25.8 mmHg诊断肺动脉高压的敏感度、特异度、阳性预测值和阴性预测值分别为86%、93%、95%和81%。
要点
- 主肺动脉容积与有创平均肺动脉压相关性最强(r=0.76,p<0.001),优于横断面径线测量。
- 主肺动脉容积联合超声心动图肺动脉收缩压预测平均肺动脉压与有创值高度相关(r=0.89,p<0.001)。
- 联合模型预测肺动脉高压AUC为0.94,高于单独主肺动脉容积(0.90)或单独超声心动图(0.92)。
核心结论
- 基于CTPA的中央肺动脉自动三维容积测量可能联合超声心动图压力估测无创预测平均肺动脉压和肺动脉高压,诊断准确性高于任一单项检查。
研究设计与样本
- 回顾性诊断准确性研究,纳入70例(平均年龄66.7岁,48例女性)因疑似肺动脉高压行CTPA和经胸超声心动图估测肺动脉收缩压的患者,以右心导管测量的有创平均肺动脉压为参考标准,采用自动三维分割计算主肺动脉、右肺动脉和左肺动脉容积并与手动横断面径线比较,建立预测平均肺动脉压的线性回归模型。
关键影像表现/征象
- 肺动脉高压患者的主肺动脉、右肺动脉和左肺动脉容积均较无肺动脉高压者显著增大(均p<0.001)。
- 主肺动脉容积与有创平均肺动脉压相关性最强(r=0.76,p<0.001)。
- 以主肺动脉容积和超声心动图肺动脉收缩压为协变量的预测平均肺动脉压与有创平均肺动脉压相关性极佳(r=0.89,p<0.001)。
诊断标准与关键数值
- 预测平均肺动脉压>25.8 mmHg诊断肺动脉高压的敏感度86%、特异度93%、阳性预测值95%、阴性预测值81%。
- 预测肺动脉高压的AUC:预测平均肺动脉压0.94,主肺动脉容积0.90,单独超声心动图肺动脉收缩压0.92。
- 主肺动脉容积与有创平均肺动脉压相关系数r=0.76(p<0.001)。
- 预测平均肺动脉压与有创平均肺动脉压相关系数r=0.89(p<0.001)。
临床应用与阅片要点
- 作者认为,基于CTPA的中央肺动脉自动三维容积测量可联合超声心动图压力估测无创预测平均肺动脉压和肺动脉高压,诊断准确性高于任一单项检查。
- 预测平均肺动脉压>25.8 mmHg可作为联合模型识别肺动脉高压的参考阈值,其敏感度86%、特异度93%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the diagnostic accuracy of automated 3D volumetry of central pulmonary arteries using computed tomography pulmonary angiography (CTPA) for suspected pulmonary hypertension alone and in combination with echocardiography.
METHODS: This retrospective diagnostic accuracy study included 70 patients (mean age 66.7, 48 female) assessed for pulmonary hypertension by CTPA and transthoracic echocardiography with estimation of the pulmonary arterial systolic pressure (PASP). Gold standard right heart catheterisation with measurement of the invasive mean pulmonary arterial pressure (invasive mPAP) served as the reference. Volumes of the main, right and left pulmonary arteries (MPA, RPA and LPA) were computed using automated 3D segmentation. For comparison, axial dimensions were manually measured. A linear regression model was established for prediction of mPAP (predicted mPAP).
RESULTS: MPA, RPA and LPA volumes were significantly increased in patients with vs. without pulmonary hypertension (all p < 0.001). Of all measures, MPA volume demonstrated the strongest correlation with invasive mPAP (r = 0.76, p < 0.001). Predicted mPAP using MPA volume and echocardiographic PASP as covariates showed excellent correlation with invasive mPAP (r = 0.89, p < 0.001). Area under the curves for predicting pulmonary hypertension were 0.94 for predicted mPAP, compared to 0.90 for MPA volume and 0.92 for echocardiographic PASP alone. A predicted mPAP > 25.8 mmHg identified pulmonary hypertension with sensitivity, specificity, positive and negative predictive values of 86%, 93%, 95% and 81%, respectively.
CONCLUSIONS: Automated 3D volumetry of central pulmonary arteries based on CTPA may be used in conjunction with echocardiographic pressure estimates to noninvasively predict mPAP and pulmonary hypertension as confirmed by gold standard right heart catheterisation with higher diagnostic accuracy than either test alone.
KEY POINTS: • This diagnostic accuracy study derived a regression model for noninvasive prediction of invasively measured mean pulmonary arterial pressure as assessed by gold standard right heart catheterisation. • This regression model using automated 3D volumetry of the central pulmonary arteries based on CT pulmonary angiography in conjunction with the echocardiographic pressure estimate predicted pulmonary arterial pressure and the presence of pulmonary hypertension with good diagnostic accuracy. • The combination of automated 3D volumetry and echocardiographic pressure estimate in the regression model provided superior diagnostic accuracy compared to each parameter alone.
引用
- Melzig C, Wörz S, Egenlauf B, et al. Combined automated 3D volumetry by pulmonary CT angiography and echocardiography for detection of pulmonary hypertension. Eur Radiol. 2019. PMID: 30963276. doi:10.1007/s00330-019-06188-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。